Moloney Securities Asset Management »

Nektar Therapeutics shares owned by Moloney Securities Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Moloney Securities Asset Management from 13F filings

Historical chart of Moloney Securities Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Moloney Securities Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Moloney Securities Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $98k 105k 0.93
2023-12-31 $65k 115k 0.57
2023-09-30 $107k 180k 0.60
2023-06-30 $204k 355k 0.58

More positions owned by Moloney Securities Asset Management

Microsoft Corporation (MSFT)
iShares S&P 500 Index (IVV)
Apple (AAPL)
iShares Lehman Aggregate Bond (AGG)
Invesco Qqq Trust Series 1 (QQQ)
Berkshire Hathaway (BRK.B)
Vanguard Total Stock Market ETF (VTI)
Invesco Senior Loan Etf otr (BKLN)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
RBB (TBIL)
Spdr S&p 500 Etf (SPY)
Alphabet Inc Class A cs (GOOGL)
Invesco Exchange Traded Fd T s&p500 pur gwt (RPG)
Exxon Mobil Corporation (XOM)

View all positions for Moloney Securities Asset Management

Top funds holding Nektar Therapeutics

Vanguard Group
Acadian Asset Management
PRIMECAP Management Company
BlackRock
Monaco Asset Management SAM
Citadel Advisors
Millennium Management
D. E. Shaw & Co
Nantahala Capital Management
Two Sigma Advisers
Two Sigma Investments
Shay Capital
Lynx1 Capital Management
Geode Capital Management
GSA Capital Partners

View all funds holding Nektar Therapeutics